Amoxapine
3 NDCs across 1 manufacturer|3 Generic,0 Brand
Amoxapine is used to treat depressive disorder and psychophysiologic disorders, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved before 1982, and the first generic was approved May 11, 1989. FDA's Orange Book lists 8 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $187K on Amoxapine across 2,142 claims for 413 beneficiaries.
Amoxapine is available as 3 NDCs from 1 manufacturer (3 generic, 0 brand), with NADAC prices from $0.42 to $1.10 per EA — the most expensive product costs about 2.6× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
3
3G / 0B
Manufacturers
1
competing in market
Price Spread
$0.42 – $1.10
per EA
7d Activity
avg +0.0% WoW · of 3 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Actavis Pharma, Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Tricyclic Antidepressant class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
1 manufacturer producing AMOXAPINE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
AMOXAPINE 100 MG TABLET | $1.1018 per EA | — |
AMOXAPINE 50 MG TABLET | $0.6825 per EA | — |
AMOXAPINE 25 MG TABLET | $0.4210 per EA | — |
Frequently Asked Questions
What is Amoxapine used to treat?
Amoxapine is used to treat depressive disorder and psychophysiologic disorders, per the National Library of Medicine's MED-RT classification.
When did Amoxapine become available as a generic?
FDA approved the first generic Amoxapine (ANDA) on May 11, 1989. The Orange Book currently lists 8 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Amoxapine?
In 2024, Medicare Part D spent $187K on Amoxapine across 2,142 claims for 413 beneficiaries.
How many Amoxapine products are on the market?
The Amoxapine drug market contains 3 NDCs from 1 manufacturer — 3 generic and 0 brand products.
What is the price range for Amoxapine?
NADAC reference prices for Amoxapine range from $0.4210 to $1.1018 per EA — the most expensive product costs about 2.6× the cheapest.
Which manufacturers make Amoxapine?
1 manufacturer lists Amoxapine in NADAC. Ranked by number of NDCs, the largest are Actavis Pharma, Inc. (3).